Publications by authors named "Jeanne M Regnante"

Article Synopsis
  • The study aims to create a framework for reducing cancer care disparities in underserved populations, following guidelines from the Institute of Medicine/National Academies of Sciences.
  • An environmental scan identified 84 experts and 44 patient organizations, leading to a roundtable that focused on priority areas like care coordination, community engagement, and healthcare system changes.
  • The developed framework and recommendations are designed to help various stakeholders improve health equity in cancer care access and outcomes.
View Article and Find Full Text PDF

Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials.

Methods: Criteria were developed to identify cancer centers able to accrue a higher than average proportion of REMGs into clinical trials.

View Article and Find Full Text PDF

Purpose: Participation of racial and ethnic minority groups (REMGs) in cancer trials is disproportionately low despite a high prevalence of certain cancers in REMG populations. We aimed to identify notable practices used by leading US cancer centers that facilitate REMG participation in cancer trials.

Methods: The National Minority Quality Forum and Sustainable Healthy Communities Diverse Cancer Communities Working Group developed criteria by which to identify eligible US cancer centers-REMGs comprise 10% or more of the catchment area; a 10% to 50% yearly accrual rate of REMGs in cancer trials; and the presence of formal community outreach and diversity enrollment programs.

View Article and Find Full Text PDF
Article Synopsis
  • Clinical trials are essential for assessing the safety and effectiveness of new medical treatments, but there is a noticeable lack of diversity among participants, particularly racial and ethnic minorities.
  • Factors that influence the willingness of minority patients to join clinical trials include cultural barriers, lack of awareness, and mistrust in the medical system.
  • This study explored these barriers through input from various stakeholders and developed potential solutions, using a behavior change framework to craft effective communication strategies to encourage greater participation among diverse populations.
View Article and Find Full Text PDF